Jun‐Ge Yu

Biochemistry, Genetics and Molecular Biology · Life Sciences

12h-index603citations74works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(41), Herpesvirus Infections and Treatments(22), Cancer Research and Treatments(20), Vitamin D Research Studies(11), RNA Interference and Gene Delivery(10)

Publications74 total

Supplemental Figures from Vitamin D Signaling Suppresses Early Prostate Carcinogenesis in TgAPT<sub>121</sub> Mice
2023Open Access
Data from Vitamin D Signaling Suppresses Early Prostate Carcinogenesis in TgAPT<sub>121</sub> Mice
2023Open Access
Data from Dietary Vitamin D and Vitamin D Receptor Level Modulate Epithelial Cell Proliferation and Apoptosis in the Prostate
2023Open Access
Data from Dietary Vitamin D and Vitamin D Receptor Level Modulate Epithelial Cell Proliferation and Apoptosis in the Prostate
2023Open Access
Supplementary Figure 1 from Dietary Vitamin D and Vitamin D Receptor Level Modulate Epithelial Cell Proliferation and Apoptosis in the Prostate
2023Open Access
Supplemental Figures from Vitamin D Signaling Suppresses Early Prostate Carcinogenesis in TgAPT<sub>121</sub> Mice
2023Open Access
Data from Vitamin D Signaling Suppresses Early Prostate Carcinogenesis in TgAPT<sub>121</sub> Mice
2023Open Access
Supplementary Tables from Vitamin D Signaling Suppresses Early Prostate Carcinogenesis in TgAPT<sub>121</sub> Mice
2023Open Access
Supplementary Tables from Vitamin D Signaling Suppresses Early Prostate Carcinogenesis in TgAPT<sub>121</sub> Mice
2023Open Access
Supplementary Figure 1 from Dietary Vitamin D and Vitamin D Receptor Level Modulate Epithelial Cell Proliferation and Apoptosis in the Prostate
2023Open Access
Supplementary Figure Legend from Bortezomib Treatment Sensitizes Oncolytic HSV-1–Treated Tumors to NK Cell Immunotherapy
2023Open Access
Supplementary Tables 1 - 2 from Bortezomib-Induced Unfolded Protein Response Increases Oncolytic HSV-1 Replication Resulting in Synergistic Antitumor Effects
2023Open Access
Supplementary Figure 1. from BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection—Implications for Oncolytic Viral Therapy
2023Open Access
Supplementary Figures from Bortezomib Treatment Sensitizes Oncolytic HSV-1–Treated Tumors to NK Cell Immunotherapy
2023Open Access
Data from Bortezomib Treatment Sensitizes Oncolytic HSV-1–Treated Tumors to NK Cell Immunotherapy
2023Open Access
Supplementary Figure 1 from Copper Chelation Enhances Antitumor Efficacy and Systemic Delivery of Oncolytic HSV
2023Open Access
Supplementary Figure 3 from Copper Chelation Enhances Antitumor Efficacy and Systemic Delivery of Oncolytic HSV
2023Open Access
Data from Bortezomib Treatment Sensitizes Oncolytic HSV-1–Treated Tumors to NK Cell Immunotherapy
2023Open Access
Supplementary Figure 5 from Copper Chelation Enhances Antitumor Efficacy and Systemic Delivery of Oncolytic HSV
2023Open Access
Supplementary Figure Legend from Copper Chelation Enhances Antitumor Efficacy and Systemic Delivery of Oncolytic HSV
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Matthew Old(26), Balveen Kaur(24), Ji Young Yoo(23), Jeffrey Wojton(20), Chelsea Bolyard(16), Jianhua Yu(16), Michael A. Caligiuri(16), Theodoros N. Teknos(10), Jianying Zhang(10), Flavia Pichiorri(9), Christopher Alvarez‐Breckenridge(9), Pavlo L. Kovalenko(8), Steven K. Clinton(8), James C. Fleet(8), W. Hans Meisen(8), Yeshavanth Banasavadi‐Siddegowda(8), Jayson Hardcastle(8), Eric S. Wohleb(8), Samuel Dubin(8), Maninder Khosla(8)